Publication | Closed Access
Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder
38
Citations
35
References
2020
Year
Endoxifen at a low daily dose of 8 mg was as efficacious and safe in patients with BPD I acute manic episodes with/without mixed features.
| Year | Citations | |
|---|---|---|
Page 1
Page 1